📋 PACIRA BIOSCIENCES, INC. (PCRX) - Clinical Trial Update
Filing Date: 2026-01-08
Accepted: 2026-01-08 16:02:31
Event Type: Clinical Trial Update
Event Details:
Pacira BioSciences Inc (PCRX) Announces Clinical Trial Update
Pacira BioSciences Inc (PCRX) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: leader, positioned
Diseases/Conditions: sustainable, three years--BRISBANE
Collaboration: EXPAREL
Updated Timeline: the year ended December 31, 2024, the year ended December 31, 2025
🔬 Clinical Development Pipeline (PACIRA BIOSCIENCES, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Placebo
DRUG
Phase PHASE1
Pain
ClinicalTrials.gov
SBS-1000
DRUG
Phase PHASE1
Pain
ClinicalTrials.gov
Omeprazole
DRUG
Phase PHASE1
KCNT1-Related Epilepsy
ClinicalTrials.gov
ABS-1230
DRUG
Phase PHASE1
KCNT1-Related Epilepsy
ClinicalTrials.gov
Continuous popliteal nerve block with unencapsulated bupivacaine
DRUG
Phase PHASE4
Moderate-to-severely Painful Ankle Surgery
ClinicalTrials.gov
Adductor canal nerve block with exclusively unencapsulated bupivacaine
DRUG
Phase PHASE4
Moderate-to-severely Painful Ankle Surgery
ClinicalTrials.gov
Popliteal nerve block with exclusively unencapsulated bupivacaine
DRUG
Phase PHASE4
Moderate-to-severely Painful Ankle Surgery
ClinicalTrials.gov
Continuous popliteal nerve block with normal saline
DRUG
Phase PHASE4
Moderate-to-severely Painful Ankle Surgery
ClinicalTrials.gov
Adductor canal nerve block including liposomal bupivacaine
DRUG
Phase PHASE4
Moderate-to-severely Painful Ankle Surgery
ClinicalTrials.gov
Popliteal nerve block including liposomal bupivacaine
📋 PACIRA BIOSCIENCES, INC. (PCRX) - Clinical Trial Update
Filing Date: 2026-01-08
Accepted: 2026-01-08 16:02:31
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (PACIRA BIOSCIENCES, INC.):
💼 Business Developments:
Structured Data: